Updated April 27, 2021:
Despite the challenge of COVID-19 throughout the crop season in 2020, we were able to have a full-scale breeding
program and things were pretty much on track. We got hit, as expected, multiple times throughout the growing season
by dicamba off-target movement. Fortunately, we had both Xtend and RR2 checks in every test so that we were able
make meaningful comparisons and selections. Overall, we had approximately 160 acres of research for breeder seed
increases, demonstrations, purifications, 36 UT lines, 250 AYT lines, 2,500 PYT lines, 30,000 progeny rows, 300 winter nursery populations, and 300 crossing block. The RR2 check averaged 70-90% of the Xtend checks across the farm and planting dates. We selected our lines using the threshold of >100% RR2 check and >80-90% of the Xtend checks depending on the maturity groups.
In 2020, we released 5 conventional—1 RR1, 1 RR2, and 1 high oleic ( HO)— lines as cultivars. Foundation Seed program grew two released MG-4 lines for increase. We grew other released lines for breeder seed increase and produced 8-20 units of seed each for commercialization in 2021. We entered 18 released and to-be released lines in state variety trials across 15 different states in 2020. Yields of these lines were comparable to the popular commercial varieties and several lines did well in several states. We entered 36 lines in the USDA Uniform Tests and our lines ranked well on top in all maturity groups.
We have approximately 300 breeding populations being advanced in Costa Rica and Puerto Rico. We made approximately 300 new crosses and they were sent to winter nurseries for generation advancement, and breeding lines will come back in 2022. We are also in the process of converting eight high-yielding lines to E3 and three other lines to Xtend. This is done by alternating greenhouse, field, and winter nursery backcrossing and may take two years to complete.